US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Carpenter Technology

195.61

-1.8300-0.93%

Pre-market: 199.003.39+1.73%04:54 EDT

Volume:603.52K

Turnover:116.98M

Market Cap:9.74B

PE:27.76

High:195.98

Open:190.33

Low:188.12

Close:197.44

Loading ...

Overview Company News Filings

Is Carpenter Technology (CRS) Stock Outpacing Its Basic Materials Peers This Year?

NV5 Acquires CRS Survey to Expand Surveying Work in North Carolina

MT Newswires Live

NV5 Acquires CRS Survey; Strengthens North Carolina Infrastructure Capabilities

Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment

BASF & Sika Unveil Epoxy Hardener for Sustainable Solutions

Kinross Gold Receives TSX Acceptance to Renew NCIB Program

LYB & Covestro Decide Permanent Shut Down of PO11 Unit at Maasvlakte

Here's Why You Should Retain Mosaic Stock in Your Portfolio

RAINIER Trial Data Update: Two Additional AML Patients Achieve Remission Within 30 Days of Treatment

ACCESS Newswire

Press Release: Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE(R) in Chronic Rhinosinusitis (CRS)

B2Gold Completes Fekola Solar Plant Expansion to Cut Fuel Costs

Ashland Wraps Up Divestment of Avoca Business to Mane

Agnico Eagle Mines Announces Investment in Collective Mining

Here's Why Carpenter Technology (CRS) is a Strong Growth Stock

American Resources Expands Rare Earth Element Purification Capacity

INAB: Introducing INB-600, A γδ T Cell Engager Platform

Zacks Small Cap Research

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

Press Release: Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Westlake Royal Building Products Launches Series 800 Patio Door

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CRS/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRS\",,,,,undefined,":{"symbol":"CRS","market":"US","secType":"STK","nameCN":"Carpenter Technology","latestPrice":195.61,"timestamp":1746043200000,"preClose":197.44,"halted":0,"volume":603518,"hourTrading":{"tag":"盘前","latestPrice":199,"preClose":195.61,"latestTime":"04:54 EDT","volume":7,"amount":1376.70001,"timestamp":1746089692491},"delay":0,"floatShares":48524032,"shares":49779343,"eps":7.045753,"marketStatus":"Pre-Mkt","change":-1.83,"latestTime":"05-01 07:24:07 EDT","open":190.33,"high":195.98,"low":188.12,"amount":116979274.7585,"amplitude":0.03981,"askPrice":222.52,"askSize":100,"bidPrice":196,"bidSize":19,"shortable":3,"etf":0,"ttmEps":7.045753,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746106200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":195.61,"dividendRate":0.00409,"preHourTrading":{"tag":"盘前","latestPrice":199,"preClose":195.61,"latestTime":"04:54 EDT","volume":7,"amount":1376.70001,"timestamp":1746089692491},"postHourTrading":{"tag":"盘后","latestPrice":195.61,"preClose":195.61,"latestTime":"18:42 EDT","volume":18484,"amount":3615675.21,"timestamp":1746052979209},"volumeRatio":0.5192009379619301,"impliedVol":0.532,"impliedVolPercentile":0.8072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRS\",,,,,undefined,":{"symbol":"CRS","floatShares":48524032,"roa":"9.25%","roe":"21.79%","lyrEps":3.746478,"volumeRatio":0.5192009379619301,"shares":49779343,"dividePrice":0.8,"high":195.98,"amplitude":0.03981,"preClose":197.44,"low":188.12,"week52Low":90.26,"pbRate":"5.47","psRate":"3.33","week52High":213.6599,"institutionHeld":0.9767,"latestPrice":195.61,"committee":-0.680672,"eps":7.045753,"divideRate":0.00409,"volume":603518,"delay":0,"ttmEps":7.045753,"open":190.33,"prevYearClose":169.71,"prevWeekClose":199,"prevMonthClose":195.61,"prevQuarterClose":181.18,"fiveDayClose":190.73,"twentyDayClose":182.69,"sixtyDayClose":191.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRS\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521307112","title":"Is Carpenter Technology (CRS) Stock Outpacing Its Basic Materials Peers This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521307112","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521307112?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:40","pubTimestamp":1742564408,"startTime":"0","endTime":"0","summary":"The Basic Materials group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Carpenter Technology  one of those stocks right now?By taking a look at the stock's year-to-date performance in comparison to its Basic Materials peers, we might be able to answer that question.Carpenter Technology is one of 232 individual stocks in the Basic Materials sector. Collectively, these companies sit at #15 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Carpenter Technology is currently sporting a Zacks Rank of #2 .Over the past three months, the Zac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/carpenter-technology-crs-stock-outpacing-134008367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B66KJ199.SGD","IE0031619046.USD","BK4588","BK4006","IE00B19Z4B17.USD","ARKG","CRS","IE00B7SZL793.SGD","BK4585","BK4093","LU2065731478.USD","BK4544","YARIY"],"gpt_icon":0},{"id":"2521289705","title":"NV5 Acquires CRS Survey to Expand Surveying Work in North Carolina","url":"https://stock-news.laohu8.com/highlight/detail?id=2521289705","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521289705?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:04","pubTimestamp":1742562276,"startTime":"0","endTime":"0","summary":"NV5  said Friday that it has acquired CRS Survey, a Charlotte-based firm that delivers land and aerial mapping services for public and private sector projects.Financial terms of the deal were not disclosed.The acquisition aims to expand NV5's surveying footprint in North Carolina, where it already has contracts with state and local transportation departments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVEE","IE0031619046.USD","BK4129","IE00B7SZL793.SGD","IE00B19Z4B17.USD","LU2065731478.USD","CARO","CRS","BK4006","IE00B66KJ199.SGD","BK4123"],"gpt_icon":0},{"id":"2521283838","title":"NV5 Acquires CRS Survey; Strengthens North Carolina Infrastructure Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2521283838","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521283838?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:00","pubTimestamp":1742558400,"startTime":"0","endTime":"0","summary":"HOLLYWOOD, Fla., March  21, 2025  (GLOBE NEWSWIRE) -- NV5, a provider of technology, certification, and consulting solutions, announced today that it has completed the acquisition of CRS Survey PLLC (","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/21/3047026/0/en/NV5-Acquires-CRS-Survey-Strengthens-North-Carolina-Infrastructure-Capabilities.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIC","LU2065731478.USD","BK4129","IE00B66KJ199.SGD","CARO","NVEE","BK4006","IE0031619046.USD","BK4123","IE00B7SZL793.SGD","IE00B19Z4B17.USD","CRS"],"gpt_icon":0},{"id":"2521493824","title":"Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2521493824","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521493824?lang=en_us&edition=fundamental","pubTime":"2025-03-21 02:26","pubTimestamp":1742495195,"startTime":"0","endTime":"0","summary":"On Thursday, Aptevo Therapeutics  announced two additional frontline Acute Myeloid Leukemia  patients have achieved remission within 30 days of treatment in the RAINIER dose optimization trial of mipletamig in combination with standard of care for patients unfit for intensive chemotherapy.9 of 10 frontline patients across two trials achieved remission when receiving the triplet combination of mipletamig + venetoclax + azacitidine .Notably, no cytokine release syndrome  has been reported in the RAINIER trial to date.Together with the addition of these interim Cohort 2 results, mipletamig has achieved a compelling overall remission rate of 90% among frontline patients, outperforming the doublet remission rate from a venetoclax + azacitidine-only study of 66%.In December 2024, Aptevo Therapeutics announced that 100% of patients achieved remission within 30 days in Cohort 1 of the RAINIER frontline acute myeloid leukemia  Phase 1b trial, including two patients who experienced complete remi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aptevo-therapeutics-says-two-additional-182635823.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B66KJ199.SGD","LU2065731478.USD","SSI","CRS","IE0031619046.USD","BK4006","CR","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4161","APVO","BK4139"],"gpt_icon":0},{"id":"2521467090","title":"BASF & Sika Unveil Epoxy Hardener for Sustainable Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2521467090","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521467090?lang=en_us&edition=fundamental","pubTime":"2025-03-20 23:51","pubTimestamp":1742485860,"startTime":"0","endTime":"0","summary":"BASF currently carries a Zacks Rank #3 .Better-ranked stocks in the basic materials space are Carpenter Technology Corporation CRS, CSW Industrials Inc. CSWI and Axalta Coating Systems Ltd. AXTACarpenter Technology currently carries a Zacks Rank #2 . CRS beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 15.7%. The company's shares have soared 181.2% in the past year. You can see the complete list of today's Zacks #1 Rank  stocks here.The Zacks Consensus Estimate for CSW Industrials’ current fiscal-year earnings is pegged at $8.50 per share. CSWI, carrying a Zacks Rank of 2 at present, surpassed the Zacks Consensus Estimate in each of the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/basf-sika-unveil-epoxy-hardener-155100452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4098","IE0031619046.USD","LU2065732104.USD","BASFY","IE00BLDYK493.USD","LU0006061336.USD","LU2065731478.USD","CSWI","AXTA","IE00B66KJ199.SGD","BK4006","IE00B19Z4B17.USD","IE0009354923.USD","IE00B64QTZ34.USD","BK4561","LU1074936037.SGD","CRS","IE00B7SZL793.SGD","BK4109","BK4086"],"gpt_icon":0},{"id":"2521092467","title":"Kinross Gold Receives TSX Acceptance to Renew NCIB Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2521092467","media":"Zacks","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521092467?lang=en_us&edition=fundamental","pubTime":"2025-03-20 23:48","pubTimestamp":1742485680,"startTime":"0","endTime":"0","summary":"Kinross Gold Corporation KGC stated that the Toronto Stock Exchange  accepted the company's notice to renew its normal course issuer bid  program.Under the NCIB program, KGC is authorized to purchase up to 110,350,160 of its common shares , representing up to 10% of its public float of 1,103,501,601 common shares, between March 24, 2025, and March 23, 2026.Kinross Gold perceives that the market price of the common shares may not always completely reflect their value and that purchasing the common shares would be in its best interests as well as an attractive and acceptable use of available funds. The company is committed to increasing shareholder returns through initiatives such as share repurchases and quarterly dividends, which are supported by its investment grade balance sheet and significant free cash flow generation from its global portfolio.Shares of Kinross Gold have surged 113.3% in the past year compared with the 47.8% growth of the industry.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kinross-gold-receives-tsx-acceptance-154800694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4086","IE0031619046.USD","BK4006","CSWI","IE00B7SZL793.SGD","BK4109","IE00B66KJ199.SGD","BK4561","CRS","IE00B64QTZ34.USD","IE0009354923.USD","AXTA","KGC","IE00B19Z4B17.USD","LU2065732104.USD","BK4017","IE00BLDYK493.USD","BK4532","LU2065731478.USD","LU1074936037.SGD","LU0006061336.USD"],"gpt_icon":0},{"id":"2520466181","title":"LYB & Covestro Decide Permanent Shut Down of PO11 Unit at Maasvlakte","url":"https://stock-news.laohu8.com/highlight/detail?id=2520466181","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520466181?lang=en_us&edition=fundamental","pubTime":"2025-03-20 22:06","pubTimestamp":1742479560,"startTime":"0","endTime":"0","summary":"LyondellBasell Industries N.V. LYB and Covestro announced to permanently shut the Propylene Oxide Styrene and Monomer  production unit  at the Maasvlakte site in the Netherlands.The Maasvlakte site is a joint venture between the two companies. This decision was taken after careful consideration of the continued pressure on Maasvlakte's profitability due to global overcapacities. High costs of European production and strong increase of imports from Asia also led to the move. The companies expect these factors to persist and as a result do not anticipate longer-term profitable production.This decision prioritizes technology differentiation, circularity and attractive returns over the cost of capital, ensured through the optimum utilization of core assets. The working relationship between all stakeholders is expected to remain the same. LyondellBasell will carry out a process to safely shut down the asset between now and the end of 2026.The Zacks Consensus Estimate for Carpenter Technolog","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lyb-covestro-decide-permanent-shut-140600303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LYB","IE0031619046.USD","IE00B7SZL793.SGD","NGVT","CRS","BK4090","BK4109","IE00B66KJ199.SGD","LU0006061336.USD","BK4585","BK4588","LU1074936037.SGD","AXTA","BK4006","IE00B19Z4B17.USD","LU2065731478.USD","BK4561"],"gpt_icon":0},{"id":"2520457439","title":"Here's Why You Should Retain Mosaic Stock in Your Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2520457439","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520457439?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:42","pubTimestamp":1742474520,"startTime":"0","endTime":"0","summary":"The Mosaic Company MOS benefits from healthy demand for phosphate and potash, high-return investments and actions to improve its cost structure amid headwinds from soft fertilizer prices.MOS’ shares are down 12.7% in a year compared with the Zacks Fertilizers industry’s 6.8% decline.Let’s find out why MOS stock is worth retaining at the moment.Weak fertilizer prices are likely to weigh on MOS’s sales and margins. Prices of phosphate and potash have retreated since the back half of 2022 from their peak levels attained in the first half, riding on the impacts of the Russia-Ukraine war and disruptions due to the sanctions in Belarus. Lower potash selling prices hurt the company’s sales in the fourth quarter. Net sales declined nearly 11% year over year to $2,815.9 million in the quarter. While prices have recovered somewhat lately, weaker year-over-year selling prices are likely to continue to dent the company’s top line in the first quarter of 2025.The Mosaic Company price-consensus-char","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-retain-mosaic-stock-124200691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NGVT","BK4561","AXTA","BK4109","BK4093","CRS","IE0031619046.USD","BK4585","BK4588","IE00B66KJ199.SGD","IE00B7SZL793.SGD","LU1074936037.SGD","LU2065731478.USD","MOS","LU2380233275.USD","IE00B19Z4B17.USD","BK4006","LU0006061336.USD"],"gpt_icon":0},{"id":"2520452538","title":"RAINIER Trial Data Update: Two Additional AML Patients Achieve Remission Within 30 Days of Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2520452538","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520452538?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:35","pubTimestamp":1742474100,"startTime":"0","endTime":"0","summary":"Across two trials, 9 of 10 frontline AML patients achieved remission when treated with mipletamig in combination with the standard of care. Triplet Combination with mipletamig continues to outperform doublet combination benchmark. No Cytokine Release Syndrome  has been observed in the RAINIER trial to date. The data builds on previously reported favorable outcomes from RAINIER's Cohort 1 and the completed dose expansion trial where 100% of frontline patients achieved remission. Together with the addition of these interim Cohort 2 results, mipletamig has achieved a compelling overall remission rate of 90% among frontline patients. This outperforms the doublet remission* rate from a venetoclax + azacitidine only study, of 66%. Additionally, the frontline patient triplet therapy CR rate of 70% outperforms the CR rate from a venetoclax + azacitidine only study of 36% .Thus far, all RAINIER patients who achieved remission remain in remission.Two patients achieved remission withing 30 days o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rainier-trial-data-two-additional-123500697.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z4B17.USD","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4161","BK4139","LU2065731478.USD","BK4006","CR","IE0031619046.USD","CRS","APVO"],"gpt_icon":0},{"id":"2520643545","title":"Press Release: Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE(R) in Chronic Rhinosinusitis (CRS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520643545","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520643545?lang=en_us&edition=fundamental","pubTime":"2025-03-20 17:27","pubTimestamp":1742462820,"startTime":"0","endTime":"0","summary":"-- Paratek will accelerate access for XHANCE beyond specialists to primary. care providers maximizing the recent label expansion for CRS in a. -- Acquisition advances Paratek's vision to become a multi-product company. consideration of $9 per share, representing a 50% premium to Optinose's. acquire Optinose, including its approved product XHANCE (fluticasone. consideration payable to shareholders of up to $14 per share, including. the payment of contingent value rights  tied to future commercial. strengthens its position as a multi-product company focused on. innovative specialty therapies for primary care providers and. XHANCE is an innovative, drug-device combination product approved for. addresses a significant unmet clinical need, improving CRS symptoms with. the potential to avoid and/or delay more invasive or expensive treatment. commercial focus on ear, nose, and throat  and allergy specialists,the XHANCE label was broadened in 2024 to include an additional. indication for CRS w","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4555","IE00B66KJ199.SGD","BK4006","CRS","IE00B7SZL793.SGD","03160","IE00B19Z4B17.USD","BK4232","LU2065731478.USD","BK4585","OPTN","TM","IE0031619046.USD","R","PRTK","BK4007","BK4588","BK4022","BK4099"],"gpt_icon":0},{"id":"2520001152","title":"B2Gold Completes Fekola Solar Plant Expansion to Cut Fuel Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2520001152","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520001152?lang=en_us&edition=fundamental","pubTime":"2025-03-19 22:53","pubTimestamp":1742395980,"startTime":"0","endTime":"0","summary":"B2Gold Corp. BTG announced the completion of the Phase 2 expansion of the Fekola Solar Plant in Mali. The plant is now operational. The expansion will reduce emissions and fuel consumption, aligning with B2Gold's sustainability targets.In June 2023, the company commenced construction of the Phase 2 Solar Plant expansion. Following initial land clearing and road construction, the physical equipment installation was completed in February 2024. The expansion entailed the addition of 46,200 solar panels, bringing the total to 142,912 panels.The construction generated more than 120 local jobs. The company trained and employed 13 individuals to maintain the Fekola Solar Plant expansion area following completion.B2Gold completed the expansion of the Fekola Solar Plant in the fourth quarter of 2024, with operations commencing in January 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/b2gold-completes-fekola-solar-plant-145300075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0498741114.HKD","AXTA","IE00B7SZL793.SGD","IE00B66KJ199.SGD","BK4006","CRS","IE00B19Z4B17.USD","BK4109","BK4017","LU0006061336.USD","LU2065731478.USD","IE0031619046.USD","SSRM","LU1074936037.SGD","BK4532","LU0496367417.USD","BK4561","LU0498741890.SGD","BTG"],"gpt_icon":0},{"id":"2520602310","title":"Ashland Wraps Up Divestment of Avoca Business to Mane","url":"https://stock-news.laohu8.com/highlight/detail?id=2520602310","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520602310?lang=en_us&edition=fundamental","pubTime":"2025-03-18 21:18","pubTimestamp":1742303880,"startTime":"0","endTime":"0","summary":"Ashland Inc. ASH recently announced the completion of its Avoca business divestment to Mane effective March 14, 2025. The terms of this transaction were not disclosed.ASH’s Avoca business provides sclareolide, a fragrance fixative, and a range of contract manufacturing capabilities from two production facilities in North Carolina and Wisconsin. Avoca was the last business line under Ashland remaining from the previous acquisition of Pharmachem. Avoca, being a strong player in this space, has a dedicated team and manufacturing capabilities to meet customer needs.The divestment is in sync with ASH’s efforts to optimize its portfolio, focus on core operations and improve margins. The company noted, earlier, that the Avoca business remained challenged over the past few quarters as customers have moved from plant-based to lower-cost bio-based materials.ASH stock has lost 40.2% in the past year compared with the 4.6% decline of the industry.The Zacks Consensus Estimate for Ingevity’s current","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ashland-wraps-divestment-avoca-business-131800667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRS","BK4561","NGVT","LU2065731478.USD","BK4006","IE0031619046.USD","IE00B19Z4B17.USD","LU2463526074.USD","IE00B7SZL793.SGD","AXTA","IE00B66KJ199.SGD","LU0006061336.USD","BK4109","ASH","LU1074936037.SGD"],"gpt_icon":0},{"id":"2520726786","title":"Agnico Eagle Mines Announces Investment in Collective Mining","url":"https://stock-news.laohu8.com/highlight/detail?id=2520726786","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520726786?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:36","pubTimestamp":1742297760,"startTime":"0","endTime":"0","summary":"In 2025, the company anticipates producing 3.3-3.5 million ounces of gold. AEM forecasts total cash costs per ounce to range from $915 to $965 and AISC per ounce to be between $1,250 and $1,300. Excluding capitalized exploration, the projected capital expenditures for 2025 are between $1.75 billion and $1.95 billion.Agnico Eagle Mines Limited price-consensus-chart | Agnico Eagle Mines Limited Quote. AEM currently carries a Zacks Rank #3 .Better-ranked stocks in the basic materials space include Carpenter Technology Corporation CRS, ArcelorMittal MT and Axalta Coating Systems Ltd. AXTACarpenter Technology currently carries a Zacks Rank #2 . CRS beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 15.7%. The company's shares have soared 178.9% in the past year. You can see the complete list of today's Zacks #1 Rank  stocks here.The Zacks Consensus Estimate for ArcelorMittal’s current-year earnings is pegged at $3.72 per share. MT, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agnico-eagle-mines-announces-investment-113600376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1223082196.USD","LU1169589451.USD","AEM","IE0031619046.USD","BK4006","IE00B7SZL793.SGD","BK4109","LU1169590202.USD","IE00B66KJ199.SGD","BK4585","SG9999001143.SGD","BK4561","CRS","LU0498741890.SGD","LU1223083913.SGD","LU0498741114.HKD","AXTA","IE00B19Z4B17.USD","LU0496367417.USD","MT","BK4017","LU2065731478.USD","LU1074936037.SGD","LU0006061336.USD"],"gpt_icon":0},{"id":"2520775576","title":"Here's Why Carpenter Technology (CRS) is a Strong Growth Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2520775576","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520775576?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:45","pubTimestamp":1742219110,"startTime":"0","endTime":"0","summary":"Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.Why This 1 Growth Stock Should Be On Your Watchlist. Different than value or momentum investors, growth-oriented investors are concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, they'll want to focus on the Growth Style Score, which analyzes characteristics like projected and historical earnings, sales, and cash flow to find stocks that will see sustainable growth over time.Carpenter Technology Corporation  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-carpenter-technology-crs-134510414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0031619046.USD","IE00B19Z4B17.USD","BK4006","IE00B66KJ199.SGD","IE00B7SZL793.SGD","CRS","LU2065731478.USD"],"gpt_icon":0},{"id":"2520547215","title":"American Resources Expands Rare Earth Element Purification Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2520547215","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520547215?lang=en_us&edition=fundamental","pubTime":"2025-03-17 17:59","pubTimestamp":1742205540,"startTime":"0","endTime":"0","summary":"AREC currently carries a Zacks Rank #3 .Better-ranked stocks in the basic materials space include Carpenter Technology Corporation CRS, ArcelorMittal MT and Axalta Coating Systems Ltd. AXTACarpenter Technology currently carries a Zacks Rank #2 . CRS beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 15.7%. The company's shares have soared 178.9% in the past year. You can see the complete list of today's Zacks #1 Rank  stocks here.The Zacks Consensus Estimate for ArcelorMittal’s current-year earnings is pegged at $3.72 per share. MT, which carries a Zacks Rank #2, surpassed the Zacks Consensus Estimate in three of the trailing four quarters and missed one, with the average earnings surprise being 4.11%. The company's shares have rallied 21.8% in the past year.Axalta Coating Systems, which currently carries a Zacks Rank #1, beat the consensus estimate in each of the trailing four quarters. In this time frame, it delivered an earn","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/american-resources-expands-rare-earth-095900998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AREC","BK4109","BK4117","IE00B19Z4B17.USD","BK4107","LU2065731478.USD","BK4561","BK4006","MT","BK4156","LU1074936037.SGD","IE0031619046.USD","AFG","CRS","IE00B66KJ199.SGD","AXTA","IE00B7SZL793.SGD","LU0006061336.USD"],"gpt_icon":0},{"id":"2520522383","title":"INAB: Introducing INB-600, A γδ T Cell Engager Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2520522383","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520522383?lang=en_us&edition=fundamental","pubTime":"2025-03-17 17:31","pubTimestamp":1742203860,"startTime":"0","endTime":"0","summary":"Following the announcement of its new γδ T cell engager platform INB-600, IN8bio, Inc.  reported 2024 financial and operational results on March 14th, 2025. Other corporate achievements since the third quarter report in mid-November include a stakeholder update on glioblastoma multiforme  and acute myeloid leukemia  efforts and presentations at multiple investor and scientific conferences.The most important information shared related to the INB-100 patients. Trial data was updated by about four months from early August 2024 to January 17th, 2025 and were presented at the Transplantation & Cellular Therapy  Meetings in February. All of the acute myeloid leukemia  patients across both original and expansion cohorts remain in complete remission , with a median follow-up of 20.1 months. All of the AML patients achieved one year of both progression free survival  and overall survival .General & administrative expenses were $12.6 million, falling 6.5% from $13.5 million. The decrease was pri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inab-introducing-inb-600-t-093100072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z4B17.USD","BK4195","OS","CR","IE00B66KJ199.SGD","BK4097","LU2065731478.USD","PFS","BK4211","INB","IE0031619046.USD","IE00B7SZL793.SGD","CRS","BK4161","BK4539","BK4139","INAB","BK4006"],"gpt_icon":0},{"id":"2519808851","title":"Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2519808851","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519808851?lang=en_us&edition=fundamental","pubTime":"2025-03-14 18:59","pubTimestamp":1741949940,"startTime":"0","endTime":"0","summary":"In the TRANSCEND FL trial, 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving complete response*. Breyanzi demonstrated sustained clinical benefit, with 75.7% of patients still in response at 18 months, and a consistent safety profile with no new safety signals observed. PRINCETON, N.J., March 14, 2025----Bristol Myers Squibb  today announced that the European Commission  has granted approval to Breyanzi , a CD19-directed chimeric antigen receptor  T cell therapy, for the treatment of adult patients with relapsed or refractory follicular lymphoma  after two or more lines of systemic therapy.This expanded approval is applicable to all European Union  member states as well as the European Economic Area  countries Iceland, Norway and Liechtenstein.** Breyanzi is also approved in the EU for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma , high grade B-cell lymphoma , primary mediastinal large B-cell lymphoma  and FL grade 3B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-receives-approval-105900919.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","CRS","LU1585245621.USD","LU2065731478.USD","HSCT","LU2133065610.SGD","BK4528","BK4201","BK4588","FL","LU0868494617.USD","LU2242652126.USD","LU0306806265.USD","IE00BSNM7G36.USD","IE00BFXG1179.USD","LU2242646821.SGD","LU1323610961.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","BK4230","BMY","LU0114720955.EUR","BK4585","LU1032466523.USD","LU2125154778.USD","BK4156","IE0031619046.USD","BK4094","BK4534","EC","BK4205","EEA","LU0225771236.USD","CR","CAR","LU2125154935.USD","LU1718418525.SGD","MYE","LU0456855351.SGD","LU0096364046.USD","LU1261432733.SGD","LU0061475181.USD","LU1670711040.USD","LU0237698245.USD","IE00B66KJ199.SGD","LU1093756325.SGD","UK","LU0882574055.USD","LU2360032135.SGD"],"gpt_icon":0},{"id":"2519691818","title":"IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2519691818","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519691818?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:05","pubTimestamp":1741896300,"startTime":"0","endTime":"0","summary":"Ongoing Phase 1 and Phase 2 clinical programs continue to exhibit long-term durable remissions in hard-to-treat cancers, includingglioblastoma (GBM) and  100% of treated Acute Myeloid Leukemia (AML) p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/13/3042590/0/en/IN8bio-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","IE00B7SZL793.SGD","IE00B66KJ199.SGD","BK4139","IE0031619046.USD","IE00B19Z4B17.USD","BK4006","CRS","BK4539","LU2065731478.USD"],"gpt_icon":0},{"id":"2519986675","title":"Press Release: Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519986675","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519986675?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:01","pubTimestamp":1741896060,"startTime":"0","endTime":"0","summary":"Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update. -- Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal. Phase 3 trial in CRS patients, expected in 2Q 2025. -- In parallel, the Company continues to analyze data and explore. opportunities for LYR-210 in CRS patient cohort with nasal polyps. \"We eagerly await the upcoming readout from the ENLIGHTEN 2 Phase 3 study in Q2 2025 which we expect will provide us with important data and enable us to gain further insight about the potential efficacy of LYR-210 across a broad CRS population, including both patients with and without nasal polyps. The data from this pivotal study will enable us to determine the path for LYR-210 to potentially add value for patients, investors and our business,\" said Maria Palasis, Ph.D., President and CEO of Lyra Therapeutics.to receive sham treatment demonstrated a durable response to LYR-210","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","BK4006","LU2065731478.USD","CRS","IE00B19Z4B17.USD","BK4007","IE00B66KJ199.SGD","LYRA","IE00B7SZL793.SGD"],"gpt_icon":0},{"id":"2519570638","title":"Westlake Royal Building Products Launches Series 800 Patio Door","url":"https://stock-news.laohu8.com/highlight/detail?id=2519570638","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519570638?lang=en_us&edition=fundamental","pubTime":"2025-03-13 23:25","pubTimestamp":1741879500,"startTime":"0","endTime":"0","summary":"Westlake Corporation’s WLK unit Westlake Royal Building Products has added Series 800 Patio Door to its Royal Window Solutions product line. These doors combine utmost performance and versatility with a variety of different features to suit projects and locations of all kinds.This product line has been designed keeping in mind the need for optimal thermal efficiency and durability, including Energy Star-compliant glazing options, an internal weep system, an all-welded frame and sash, and dual-seal weatherstripping to withstand the weather conditions. Standard-height Series 800 doors have also secured a DP50 rating.Series 800 is available up to 12’ wide and heights up to 8’. It also has customizable options like stainless steel rollers and mortises for coastal applications, dual-point locking, ADA-compliant sizes, an integral J-channel and grids. The doors have been integrated with styles and efficiency, making it an easy choice for pros.The Zacks Consensus Estimate for ArcelorMittal’s ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/westlake-royal-building-products-launches-152500886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4006","BK4017","MT","BK4561","IE0031619046.USD","RGLD","LU0345780521.USD","NGVT","IE00B19Z4B17.USD","WLK","BK4585","BK4109","BK4588","BK4090","IE00B7SZL793.SGD","LU0345780281.USD","CRS","LU2065731478.USD","IE00B66KJ199.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRS\",params:#limit:5,,,undefined,":[{"date":"2025-04-24","symbol":"CRS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.74,"defaultRemindTime":1745481600000,"name":null,"time":"Pre-Market","dateTimestamp":1745467200000,"actualEps":null},{"date":"2025-04-22","symbol":"CRS","amount":0.2,"announcedDate":"2025-04-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-22","defaultRemindTime":1745328600000,"name":"卡朋特科技","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-05","payableDate":"2025-04-22","currency":"USD","dateTimestamp":1745294400000,"payDate":"2025-06-05"},{"market":"US","date":"2025-01-30","symbol":"CRS","fiscalQuarterEnding":"2024/12","expectedEps":1.56,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":1.66},{"date":"2025-01-28","symbol":"CRS","amount":0.2,"announcedDate":"2025-01-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-28","defaultRemindTime":1738074600000,"name":"卡朋特科技","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-06","payableDate":"2025-01-28","currency":"USD","dateTimestamp":1738040400000,"payDate":"2025-03-06"},{"market":"US","date":"2024-10-24","symbol":"CRS","fiscalQuarterEnding":"2024/09","expectedEps":1.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1729742400000,"reportTimeType":"pre","actualEps":1.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRS\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-08","recordDate":"2015-05-12","paymentDate":"2015-06-04","value":0.18,"currency":"USD"},{"executeDate":"2015-09-03","recordDate":"2015-09-08","paymentDate":"2015-09-15","value":0.18,"currency":"USD"},{"executeDate":"2015-10-23","recordDate":"2015-10-27","paymentDate":"2015-12-03","value":0.18,"currency":"USD"},{"executeDate":"2016-02-05","recordDate":"2016-02-09","paymentDate":"2016-03-03","value":0.18,"currency":"USD"},{"executeDate":"2016-04-29","recordDate":"2016-05-03","paymentDate":"2016-06-02","value":0.18,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":8,"updateTime":1744257600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRS","date":"2025-04-29","current":27.678372,"percent":0.615948,"low":-450.702526,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"high":779.541015,"avg":21.556345,"sd":172.577681,"marketCap":9906089257},"quantilePoints":[{"date":"2020-05-01","current":6.066257,"twenty":12.550373,"median":14.871003,"eighty":31.363395,"marketCap":1023984171},{"date":"2020-05-08","current":6.12573,"twenty":12.513375,"median":14.855114,"eighty":31.363395,"marketCap":1034023231},{"date":"2020-05-15","current":5.451701,"twenty":12.476487,"median":14.840053,"eighty":31.363395,"marketCap":920247212},{"date":"2020-05-22","current":6.355126,"twenty":12.409271,"median":14.811886,"eighty":31.363395,"marketCap":1072745322},{"date":"2020-05-29","current":6.618507,"twenty":12.279474,"median":14.794335,"eighty":31.363395,"marketCap":1117204018},{"date":"2020-06-05","current":8.289418,"twenty":12.18477,"median":14.791576,"eighty":31.363395,"marketCap":1399253813},{"date":"2020-06-12","current":6.859232,"twenty":12.011817,"median":14.744522,"eighty":31.363395,"marketCap":1157838311},{"date":"2020-06-19","current":6.904545,"twenty":11.876279,"median":14.710272,"eighty":31.363395,"marketCap":1165487119},{"date":"2020-06-26","current":6.510889,"twenty":11.819339,"median":14.696803,"eighty":31.363395,"marketCap":1099038099},{"date":"2020-07-02","current":6.850736,"twenty":11.707156,"median":14.695938,"eighty":31.363395,"marketCap":1156404159},{"date":"2020-07-10","current":6.397607,"twenty":11.632246,"median":14.686264,"eighty":31.363395,"marketCap":1079916079},{"date":"2020-07-17","current":6.400439,"twenty":11.570452,"median":14.675322,"eighty":31.363395,"marketCap":1080394130},{"date":"2020-07-24","current":6.335302,"twenty":11.507603,"median":14.675322,"eighty":31.363395,"marketCap":1069398968},{"date":"2020-07-31","current":712.613945,"twenty":11.441699,"median":14.686264,"eighty":31.478456,"marketCap":1068920918},{"date":"2020-08-07","current":760.418995,"twenty":11.441699,"median":14.707036,"eighty":31.833206,"marketCap":1140628493},{"date":"2020-08-14","current":711.657844,"twenty":11.441699,"median":14.727744,"eighty":32.001037,"marketCap":1067486766},{"date":"2020-08-21","current":656.522687,"twenty":11.441699,"median":14.757218,"eighty":32.218415,"marketCap":984784030},{"date":"2020-08-28","current":688.71142,"twenty":11.441699,"median":14.792279,"eighty":32.38392,"marketCap":1033067130},{"date":"2020-09-04","current":687.436619,"twenty":11.441699,"median":14.811141,"eighty":32.561129,"marketCap":1031154928},{"date":"2020-09-11","current":622.988209,"twenty":11.441699,"median":14.817462,"eighty":32.661083,"marketCap":934482313},{"date":"2020-09-18","current":639.929397,"twenty":11.441699,"median":14.845074,"eighty":32.730017,"marketCap":959894095},{"date":"2020-09-25","current":580.475417,"twenty":11.487036,"median":14.863913,"eighty":32.794235,"marketCap":870713125},{"date":"2020-10-02","current":602.85057,"twenty":11.570452,"median":14.878619,"eighty":32.923034,"marketCap":904275855},{"date":"2020-10-09","current":603.489861,"twenty":11.578691,"median":14.927909,"eighty":33.17292,"marketCap":905234791},{"date":"2020-10-16","current":590.704058,"twenty":11.578691,"median":14.969455,"eighty":33.81401,"marketCap":886056087},{"date":"2020-10-23","current":-10.250934,"twenty":11.597644,"median":14.982648,"eighty":34.169021,"marketCap":889781081},{"date":"2020-10-30","current":-9.670066,"twenty":11.562752,"median":14.982648,"eighty":34.169021,"marketCap":839361754},{"date":"2020-11-06","current":-10.450089,"twenty":11.441699,"median":14.969455,"eighty":34.169021,"marketCap":907067708},{"date":"2020-11-13","current":-12.80122,"twenty":11.298333,"median":14.968071,"eighty":34.169021,"marketCap":1111145937},{"date":"2020-11-20","current":-14.10679,"twenty":11.22279,"median":14.927909,"eighty":34.169021,"marketCap":1224469378},{"date":"2020-11-27","current":-14.283816,"twenty":11.111874,"median":14.922141,"eighty":34.169021,"marketCap":1239835268},{"date":"2020-12-04","current":-16.380473,"twenty":11.06034,"median":14.875718,"eighty":34.169021,"marketCap":1421825031},{"date":"2020-12-11","current":-15.605982,"twenty":10.902143,"median":14.858309,"eighty":34.169021,"marketCap":1354599261},{"date":"2020-12-18","current":-15.384699,"twenty":10.746585,"median":14.858309,"eighty":34.169021,"marketCap":1335391898},{"date":"2020-12-24","current":-15.838329,"twenty":10.564431,"median":14.858309,"eighty":34.169021,"marketCap":1374766992},{"date":"2020-12-31","current":-16.109401,"twenty":10.54371,"median":14.858309,"eighty":34.169021,"marketCap":1398296011},{"date":"2021-01-08","current":-18.394148,"twenty":10.37794,"median":14.858309,"eighty":34.169021,"marketCap":1596612032},{"date":"2021-01-15","current":-19.749506,"twenty":10.28349,"median":14.858309,"eighty":34.169021,"marketCap":1714257129},{"date":"2021-01-22","current":-19.295876,"twenty":10.220363,"median":14.858309,"eighty":34.169021,"marketCap":1674882036},{"date":"2021-01-29","current":-7.126342,"twenty":10.149233,"median":14.858309,"eighty":34.169021,"marketCap":1500095034},{"date":"2021-02-05","current":-7.503915,"twenty":10.085916,"median":14.858309,"eighty":34.169021,"marketCap":1579574153},{"date":"2021-02-12","current":-8.183808,"twenty":9.922905,"median":14.858309,"eighty":34.169021,"marketCap":1722691543},{"date":"2021-02-19","current":-8.747343,"twenty":9.777508,"median":14.858309,"eighty":34.169021,"marketCap":1841315689},{"date":"2021-02-26","current":-9.276655,"twenty":9.528674,"median":14.858309,"eighty":34.169021,"marketCap":1952735940},{"date":"2021-03-05","current":-9.532185,"twenty":9.245021,"median":14.86278,"eighty":34.225892,"marketCap":2006525026},{"date":"2021-03-12","current":-10.670663,"twenty":8.796866,"median":14.857368,"eighty":34.225892,"marketCap":2246174616},{"date":"2021-03-19","current":-9.657669,"twenty":8.449906,"median":14.850094,"eighty":34.225892,"marketCap":2032939310},{"date":"2021-03-26","current":-9.35879,"twenty":8.214652,"median":14.817462,"eighty":34.169021,"marketCap":1970025289},{"date":"2021-04-01","current":-9.43408,"twenty":7.648108,"median":14.799544,"eighty":34.169021,"marketCap":1985873859},{"date":"2021-04-09","current":-9.408983,"twenty":7.303864,"median":14.791927,"eighty":34.225892,"marketCap":1980591002},{"date":"2021-04-16","current":-9.507089,"twenty":7.00933,"median":14.757218,"eighty":34.225892,"marketCap":2001242169},{"date":"2021-04-23","current":-9.226462,"twenty":6.901712,"median":14.718684,"eighty":34.225892,"marketCap":1942170226},{"date":"2021-04-30","current":-6.252126,"twenty":6.845071,"median":14.691101,"eighty":34.225892,"marketCap":1818743483},{"date":"2021-05-07","current":-6.827566,"twenty":6.680812,"median":14.669715,"eighty":34.225892,"marketCap":1986139078},{"date":"2021-05-14","current":-6.989381,"twenty":6.510889,"median":14.636148,"eighty":34.225892,"marketCap":2033210814},{"date":"2021-05-21","current":-7.331172,"twenty":6.440088,"median":14.624868,"eighty":34.225892,"marketCap":2132637849},{"date":"2021-05-28","current":-7.912382,"twenty":6.355126,"median":14.597517,"eighty":34.225892,"marketCap":2301711841},{"date":"2021-06-04","current":-7.242009,"twenty":6.31831,"median":14.571052,"eighty":34.225892,"marketCap":2106700362},{"date":"2021-06-11","current":-7.317962,"twenty":6.189734,"median":14.536548,"eighty":34.169021,"marketCap":2128795258},{"date":"2021-06-18","current":-6.657496,"twenty":6.063242,"median":14.51697,"eighty":34.169021,"marketCap":1936665722},{"date":"2021-06-25","current":-6.67731,"twenty":5.829497,"median":14.493357,"eighty":34.169021,"marketCap":1942429608},{"date":"2021-07-02","current":-6.447799,"twenty":5.654605,"median":14.470523,"eighty":34.169021,"marketCap":1875664595},{"date":"2021-07-09","current":-6.622822,"twenty":5.508909,"median":14.438769,"eighty":34.169021,"marketCap":1926578922},{"date":"2021-07-16","current":-6.112612,"twenty":5.404021,"median":14.40732,"eighty":34.169021,"marketCap":1778158855},{"date":"2021-07-23","current":-6.243054,"twenty":5.187595,"median":14.362613,"eighty":34.169021,"marketCap":1816104439},{"date":"2021-07-30","current":-7.980991,"twenty":5.05287,"median":14.330091,"eighty":34.11215,"marketCap":1832435449},{"date":"2021-08-06","current":-7.765514,"twenty":4.832996,"median":14.303431,"eighty":34.11215,"marketCap":1782962094},{"date":"2021-08-13","current":-7.72995,"twenty":4.358193,"median":14.289447,"eighty":34.11215,"marketCap":1774796588},{"date":"2021-08-20","current":-6.763445,"twenty":-6.13837,"median":14.251985,"eighty":34.11215,"marketCap":1552886974},{"date":"2021-08-27","current":-7.157737,"twenty":-6.259562,"median":14.225364,"eighty":34.11215,"marketCap":1643416337},{"date":"2021-09-03","current":-6.975601,"twenty":-6.333208,"median":14.178684,"eighty":34.11215,"marketCap":1601597904},{"date":"2021-09-10","current":-6.619703,"twenty":-6.445817,"median":14.149507,"eighty":34.11215,"marketCap":1519883725},{"date":"2021-09-17","current":-6.609235,"twenty":-6.563514,"median":14.138554,"eighty":34.11215,"marketCap":1517480367},{"date":"2021-09-24","current":-6.841616,"twenty":-6.60093,"median":14.085675,"eighty":34.11215,"marketCap":1570834919},{"date":"2021-10-01","current":-7.170298,"twenty":-6.621574,"median":14.055464,"eighty":34.11215,"marketCap":1646300367},{"date":"2021-10-08","current":-6.973507,"twenty":-6.672026,"median":13.993043,"eighty":34.11215,"marketCap":1601117232},{"date":"2021-10-15","current":-7.048874,"twenty":-6.705955,"median":13.980331,"eighty":34.11215,"marketCap":1618421411},{"date":"2021-10-22","current":-6.705537,"twenty":-6.80716,"median":13.928396,"eighty":34.11215,"marketCap":1539591262},{"date":"2021-10-29","current":-7.541903,"twenty":-6.825286,"median":13.903764,"eighty":34.05528,"marketCap":1488017462},{"date":"2021-11-05","current":-8.00106,"twenty":-6.851665,"median":13.83802,"eighty":34.05528,"marketCap":1578609199},{"date":"2021-11-12","current":-8.31612,"twenty":-6.907352,"median":13.791799,"eighty":34.05528,"marketCap":1640770550},{"date":"2021-11-19","current":-7.480845,"twenty":-6.929962,"median":13.765103,"eighty":34.05528,"marketCap":1475970689},{"date":"2021-11-26","current":-7.146246,"twenty":-6.978113,"median":13.706435,"eighty":34.05528,"marketCap":1409954370},{"date":"2021-12-03","current":-6.884917,"twenty":-6.981881,"median":13.63571,"eighty":34.05528,"marketCap":1358394179},{"date":"2021-12-10","current":-7.224401,"twenty":-6.994861,"median":13.57876,"eighty":33.936368,"marketCap":1425374240},{"date":"2021-12-17","current":-7.458864,"twenty":-7.02802,"median":13.539792,"eighty":33.496912,"marketCap":1471633850},{"date":"2021-12-23","current":-7.077861,"twenty":-7.039534,"median":13.519346,"eighty":33.496912,"marketCap":1396461984},{"date":"2021-12-31","current":-7.12915,"twenty":-7.066051,"median":13.45606,"eighty":33.496912,"marketCap":1406581273},{"date":"2022-01-07","current":-7.932675,"twenty":-7.091184,"median":13.431482,"eighty":33.400404,"marketCap":1565116813},{"date":"2022-01-14","current":-7.974195,"twenty":-7.129269,"median":13.381664,"eighty":33.107884,"marketCap":1573308619},{"date":"2022-01-21","current":-7.114496,"twenty":-7.147711,"median":13.368154,"eighty":32.88775,"marketCap":1403690048},{"date":"2022-01-28","current":-7.029015,"twenty":-7.160249,"median":13.326394,"eighty":32.776514,"marketCap":1386824565},{"date":"2022-02-04","current":-9.851468,"twenty":-7.191153,"median":13.275258,"eighty":32.442808,"marketCap":1395953072},{"date":"2022-02-11","current":-13.193201,"twenty":-7.232126,"median":13.242532,"eighty":32.193446,"marketCap":1869476573},{"date":"2022-02-18","current":-12.968375,"twenty":-7.26807,"median":13.187778,"eighty":31.47225,"marketCap":1837618722},{"date":"2022-02-25","current":-13.165949,"twenty":-7.299087,"median":13.169615,"eighty":17.092068,"marketCap":1865615015},{"date":"2022-03-04","current":-12.474439,"twenty":-7.319765,"median":13.0994,"eighty":16.85449,"marketCap":1767627991},{"date":"2022-03-11","current":-11.871496,"twenty":-7.421217,"median":13.034267,"eighty":16.715734,"marketCap":1682191029},{"date":"2022-03-18","current":-12.954749,"twenty":-7.462036,"median":12.879448,"eighty":16.303153,"marketCap":1835687944},{"date":"2022-03-25","current":-14.504686,"twenty":-7.515082,"median":12.802432,"eighty":16.256541,"marketCap":2055314032},{"date":"2022-04-01","current":-14.766983,"twenty":-7.582461,"median":12.767221,"eighty":16.18078,"marketCap":2092481524},{"date":"2022-04-08","current":-13.779111,"twenty":-7.620731,"median":12.594144,"eighty":16.089337,"marketCap":1952500061},{"date":"2022-04-14","current":-14.463809,"twenty":-7.6687,"median":12.549841,"eighty":15.995398,"marketCap":2049521696},{"date":"2022-04-22","current":-13.768892,"twenty":-7.706324,"median":12.48713,"eighty":15.944544,"marketCap":1951051977},{"date":"2022-04-29","current":-16.93868,"twenty":-7.80714,"median":12.285392,"eighty":15.831326,"marketCap":1842928364},{"date":"2022-05-06","current":-15.430259,"twenty":-7.890014,"median":11.834154,"eighty":15.671927,"marketCap":1678812166},{"date":"2022-05-13","current":-14.732062,"twenty":-7.939552,"median":11.674871,"eighty":15.625444,"marketCap":1602848324},{"date":"2022-05-20","current":-14.403697,"twenty":-7.995198,"median":11.60329,"eighty":15.577684,"marketCap":1567122187},{"date":"2022-05-27","current":-16.023336,"twenty":-8.084816,"median":11.482348,"eighty":15.550272,"marketCap":1743338946},{"date":"2022-06-03","current":-15.535225,"twenty":-8.185212,"median":11.217373,"eighty":15.538022,"marketCap":1690232525},{"date":"2022-06-10","current":-14.314949,"twenty":-8.336657,"median":10.984637,"eighty":15.511601,"marketCap":1557466474},{"date":"2022-06-17","current":-13.130172,"twenty":-8.723615,"median":10.774911,"eighty":15.479597,"marketCap":1428562708},{"date":"2022-06-24","current":-13.121297,"twenty":-8.876021,"median":10.579851,"eighty":15.401151,"marketCap":1427597137},{"date":"2022-07-01","current":-12.158388,"twenty":-9.25749,"median":10.54371,"eighty":15.37648,"marketCap":1322832653},{"date":"2022-07-08","current":-11.577093,"twenty":-9.332781,"median":10.464198,"eighty":15.337478,"marketCap":1259587734},{"date":"2022-07-15","current":-12.25601,"twenty":-9.427235,"median":10.322041,"eighty":15.309248,"marketCap":1333453937},{"date":"2022-07-22","current":-12.517815,"twenty":-9.521691,"median":10.228073,"eighty":15.261138,"marketCap":1361938290},{"date":"2022-07-29","current":-31.602302,"twenty":-9.546869,"median":10.170246,"eighty":15.207938,"marketCap":1551673046},{"date":"2022-08-05","current":-33.490181,"twenty":-9.672279,"median":10.085916,"eighty":15.174821,"marketCap":1644367889},{"date":"2022-08-12","current":-36.675976,"twenty":-9.788172,"median":9.92623,"eighty":15.065191,"marketCap":1800790437},{"date":"2022-08-19","current":-37.521589,"twenty":-9.968368,"median":9.772689,"eighty":15.019966,"marketCap":1842310002},{"date":"2022-08-26","current":-36.754563,"twenty":-10.063588,"median":9.527906,"eighty":15.004808,"marketCap":1804649058},{"date":"2022-09-02","current":-32.101215,"twenty":-10.201618,"median":9.245021,"eighty":14.970589,"marketCap":1576169667},{"date":"2022-09-09","current":-35.308385,"twenty":-10.36067,"median":8.847464,"eighty":14.926403,"marketCap":1733641721},{"date":"2022-09-16","current":-35.446117,"twenty":-10.675455,"median":8.541465,"eighty":14.875756,"marketCap":1740404325},{"date":"2022-09-23","current":-32.789871,"twenty":-11.559344,"median":8.289418,"eighty":14.84909,"marketCap":1609982685},{"date":"2022-09-30","current":-30.635361,"twenty":-11.845143,"median":7.640878,"eighty":14.814116,"marketCap":1504196244},{"date":"2022-10-07","current":-33.389986,"twenty":-12.192577,"median":7.303864,"eighty":14.792584,"marketCap":1639448315},{"date":"2022-10-14","current":-32.927603,"twenty":-12.250128,"median":7.00933,"eighty":14.766319,"marketCap":1616745289},{"date":"2022-10-21","current":-35.701903,"twenty":-12.401516,"median":6.901712,"eighty":14.727355,"marketCap":1752963446},{"date":"2022-10-28","current":-42.377552,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1745955133},{"date":"2022-11-04","current":-45.587616,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1878209781},{"date":"2022-11-11","current":-46.998633,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1936343692},{"date":"2022-11-18","current":-48.197998,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1985757516},{"date":"2022-11-25","current":-48.150964,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1983819719},{"date":"2022-12-02","current":-50.385075,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":2075865079},{"date":"2022-12-09","current":-46.234332,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1904854490},{"date":"2022-12-16","current":-44.01198,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1813293580},{"date":"2022-12-23","current":-44.447044,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1831218202},{"date":"2022-12-30","current":-43.435815,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1789555566},{"date":"2023-01-06","current":-45.846303,"twenty":-12.595028,"median":6.777102,"eighty":14.682147,"marketCap":1888867664},{"date":"2023-01-13","current":-52.442808,"twenty":-12.732349,"median":6.618507,"eighty":14.664985,"marketCap":2160643699},{"date":"2023-01-20","current":-52.066537,"twenty":-12.847955,"median":6.510889,"eighty":14.63597,"marketCap":2145141323},{"date":"2023-01-27","current":-425.668309,"twenty":-12.960199,"median":6.414599,"eighty":14.624201,"marketCap":2383742530},{"date":"2023-02-03","current":-441.347178,"twenty":-13.077381,"median":6.343798,"eighty":14.600968,"marketCap":2471544198},{"date":"2023-02-10","current":-427.400781,"twenty":-13.129156,"median":6.274928,"eighty":14.600968,"marketCap":2393444372},{"date":"2023-02-17","current":-435.283527,"twenty":-13.338316,"median":6.083249,"eighty":14.593148,"marketCap":2437587752},{"date":"2023-02-24","current":-409.729569,"twenty":-13.478662,"median":6.020944,"eighty":14.555551,"marketCap":2294485585},{"date":"2023-03-03","current":-450.702526,"twenty":-13.745087,"median":5.786317,"eighty":14.527768,"marketCap":2523934144},{"date":"2023-03-10","current":-390.759003,"twenty":-13.855323,"median":5.616366,"eighty":14.502617,"marketCap":2188250417},{"date":"2023-03-17","current":-332.547952,"twenty":-13.950796,"median":5.451701,"eighty":14.489684,"marketCap":1862268533},{"date":"2023-03-24","current":-355.156709,"twenty":-14.107889,"median":5.340195,"eighty":14.489684,"marketCap":1988877569},{"date":"2023-03-31","current":-387.727177,"twenty":-14.303115,"median":5.127756,"eighty":14.48846,"marketCap":2171272194},{"date":"2023-04-06","current":-360.354124,"twenty":-14.415719,"median":4.983031,"eighty":14.48846,"marketCap":2017983094},{"date":"2023-04-14","current":-391.538615,"twenty":-14.49651,"median":4.827685,"eighty":14.490909,"marketCap":2192616246},{"date":"2023-04-21","current":-410.422557,"twenty":-14.720939,"median":4.327125,"eighty":14.471026,"marketCap":2298366322},{"date":"2023-04-28","current":126.995225,"twenty":-14.772654,"median":-6.134077,"eighty":14.461866,"marketCap":2616101641},{"date":"2023-05-05","current":117.180335,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2413914899},{"date":"2023-05-12","current":116.75611,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2405175867},{"date":"2023-05-19","current":111.712548,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2301278484},{"date":"2023-05-26","current":108.153773,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2227967714},{"date":"2023-06-02","current":108.884382,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2243018269},{"date":"2023-06-09","current":122.176761,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2516841279},{"date":"2023-06-16","current":122.624554,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2526065813},{"date":"2023-06-23","current":123.001643,"twenty":-14.776435,"median":-6.181961,"eighty":14.441982,"marketCap":2533833842},{"date":"2023-06-30","current":131.109051,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2700846457},{"date":"2023-07-07","current":126.136193,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2598405580},{"date":"2023-07-14","current":137.40172,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2830475435},{"date":"2023-07-21","current":135.304164,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2787265776},{"date":"2023-07-28","current":50.68501,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2858634539},{"date":"2023-08-04","current":49.652027,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2800374324},{"date":"2023-08-11","current":49.565945,"twenty":-14.780872,"median":-6.20838,"eighty":14.471362,"marketCap":2795519306},{"date":"2023-08-18","current":49.809336,"twenty":-14.780872,"median":-6.20838,"eighty":14.502171,"marketCap":2809246524},{"date":"2023-08-25","current":50.051843,"twenty":-14.780872,"median":-6.20838,"eighty":14.549981,"marketCap":2822923955},{"date":"2023-09-01","current":54.243761,"twenty":-14.78531,"median":-6.224066,"eighty":14.53565,"marketCap":3059348110},{"date":"2023-09-08","current":53.741424,"twenty":-14.78531,"median":-6.224066,"eighty":14.597174,"marketCap":3031016290},{"date":"2023-09-15","current":60.046622,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3386629482},{"date":"2023-09-22","current":59.578929,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3360251581},{"date":"2023-09-29","current":59.067931,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3331431281},{"date":"2023-10-06","current":56.634193,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3194168496},{"date":"2023-10-13","current":58.444339,"twenty":-14.78531,"median":-6.224066,"eighty":14.683568,"marketCap":3296260745},{"date":"2023-10-20","current":53.905982,"twenty":-14.78531,"median":-6.224066,"eighty":14.76393,"marketCap":3040297403},{"date":"2023-10-27","current":29.413584,"twenty":-14.798622,"median":-6.243054,"eighty":14.799544,"marketCap":3153136205},{"date":"2023-11-03","current":30.931489,"twenty":-14.798622,"median":-6.243054,"eighty":15.01852,"marketCap":3315855601},{"date":"2023-11-10","current":30.439345,"twenty":-14.798622,"median":-6.243054,"eighty":15.226052,"marketCap":3263097750},{"date":"2023-11-17","current":30.770507,"twenty":-14.798622,"median":-6.243054,"eighty":15.307189,"marketCap":3298598360},{"date":"2023-11-24","current":31.53402,"twenty":-14.798622,"median":-6.243054,"eighty":15.385027,"marketCap":3380446989},{"date":"2023-12-01","current":32.568903,"twenty":-14.798622,"median":-6.243054,"eighty":15.486556,"marketCap":3491386396},{"date":"2023-12-08","current":29.648234,"twenty":-14.794185,"median":-6.241403,"eighty":15.536881,"marketCap":3178290737},{"date":"2023-12-15","current":31.27645,"twenty":-14.794185,"median":-6.241403,"eighty":15.632081,"marketCap":3352835404},{"date":"2023-12-22","current":32.449317,"twenty":-14.794185,"median":-6.241403,"eighty":15.801544,"marketCap":3478566731},{"date":"2023-12-29","current":32.909264,"twenty":-14.798622,"median":-6.243054,"eighty":15.948971,"marketCap":3527873134},{"date":"2024-01-05","current":31.235054,"twenty":-14.79951,"median":-6.24759,"eighty":16.017891,"marketCap":3348397827},{"date":"2024-01-12","current":30.857897,"twenty":-14.79951,"median":-6.24759,"eighty":16.17357,"marketCap":3307966577},{"date":"2024-01-19","current":30.315159,"twenty":-14.800397,"median":-6.252126,"eighty":16.273067,"marketCap":3249785021},{"date":"2024-01-26","current":21.233342,"twenty":-14.79951,"median":-6.24759,"eighty":16.768529,"marketCap":3049107961},{"date":"2024-02-02","current":20.907358,"twenty":-14.79951,"median":-6.24759,"eighty":16.918792,"marketCap":3002296634},{"date":"2024-02-09","current":21.609317,"twenty":-14.79951,"median":-6.24759,"eighty":17.196305,"marketCap":3103097903},{"date":"2024-02-16","current":22.789571,"twenty":-14.79951,"median":-6.24759,"eighty":21.052567,"marketCap":3272582391},{"date":"2024-02-23","current":22.345685,"twenty":-14.79951,"median":-6.24759,"eighty":21.629963,"marketCap":3208840411},{"date":"2024-03-01","current":22.245897,"twenty":-14.798622,"median":-6.243054,"eighty":21.891477,"marketCap":3194510819},{"date":"2024-03-08","current":23.543144,"twenty":-14.798622,"median":-6.243054,"eighty":22.245897,"marketCap":3380795518},{"date":"2024-03-15","current":22.287189,"twenty":-14.798622,"median":-6.243054,"eighty":22.345685,"marketCap":3200440305},{"date":"2024-03-22","current":23.539703,"twenty":-14.798622,"median":-6.243054,"eighty":22.455796,"marketCap":3380301394},{"date":"2024-03-28","current":24.152197,"twenty":-14.798622,"median":-6.243054,"eighty":22.668584,"marketCap":3468255443},{"date":"2024-04-05","current":26.4955,"twenty":-14.79951,"median":-6.24759,"eighty":23.333245,"marketCap":3804753799},{"date":"2024-04-12","current":27.142403,"twenty":-14.79951,"median":-6.24759,"eighty":23.547273,"marketCap":3897649086},{"date":"2024-04-19","current":27.314452,"twenty":-14.79951,"median":-6.24759,"eighty":24.616728,"marketCap":3922355280},{"date":"2024-04-26","current":28.129963,"twenty":-14.798622,"median":-6.243054,"eighty":26.60217,"marketCap":4039462637},{"date":"2024-05-03","current":37.595563,"twenty":-14.798622,"median":-6.243054,"eighty":26.863684,"marketCap":4936297461},{"date":"2024-05-10","current":40.090886,"twenty":-14.798622,"median":-6.243054,"eighty":27.665431,"marketCap":5263933317},{"date":"2024-05-17","current":41.553064,"twenty":-14.798622,"median":-6.243054,"eighty":28.811276,"marketCap":5455917314},{"date":"2024-05-24","current":40.922098,"twenty":-14.798622,"median":-6.243054,"eighty":29.413584,"marketCap":5373071507},{"date":"2024-05-31","current":41.911997,"twenty":-14.798622,"median":-6.243054,"eighty":30.154177,"marketCap":5503045169},{"date":"2024-06-07","current":40.249572,"twenty":-14.798622,"median":-6.243054,"eighty":30.439345,"marketCap":5284768790},{"date":"2024-06-14","current":39.550598,"twenty":-14.79951,"median":-6.24759,"eighty":30.613205,"marketCap":5192993494},{"date":"2024-06-21","current":37.196755,"twenty":-14.800397,"median":-6.252126,"eighty":30.726352,"marketCap":4883933984},{"date":"2024-06-28","current":40.449819,"twenty":-14.80306,"median":-6.267822,"eighty":30.857897,"marketCap":5311061172},{"date":"2024-07-05","current":40.25335,"twenty":-14.80306,"median":-6.267822,"eighty":30.977484,"marketCap":5285264872},{"date":"2024-07-12","current":41.364152,"twenty":-14.80306,"median":-6.267822,"eighty":31.235054,"marketCap":5431113180},{"date":"2024-07-15","current":41.92711,"twenty":-14.80306,"median":-6.267822,"eighty":31.262651,"marketCap":5505029499},{"date":"2024-08-02","current":38.287475,"twenty":-14.910808,"median":-6.366387,"eighty":31.421793,"marketCap":7140614095},{"date":"2024-08-09","current":37.188911,"twenty":-14.910808,"median":-6.366387,"eighty":31.644408,"marketCap":6935731949},{"date":"2024-08-16","current":38.423418,"twenty":-14.910808,"median":-6.366387,"eighty":32.257102,"marketCap":7165967538},{"date":"2024-08-23","current":38.064546,"twenty":-14.910808,"median":-6.366387,"eighty":32.751042,"marketCap":7099037890},{"date":"2024-08-30","current":38.20381,"twenty":-14.910808,"median":-6.366387,"eighty":33.893553,"marketCap":7125010589},{"date":"2024-09-06","current":36.388024,"twenty":-14.910808,"median":-6.366387,"eighty":36.083622,"marketCap":6786366553},{"date":"2024-09-13","current":37.395009,"twenty":-14.910808,"median":-6.366387,"eighty":36.366599,"marketCap":6974169145},{"date":"2024-09-20","current":41.511325,"twenty":-14.910808,"median":-6.366387,"eighty":37.017881,"marketCap":7741862190},{"date":"2024-09-27","current":41.8086,"twenty":-14.910808,"median":-6.366387,"eighty":37.427756,"marketCap":7797303912},{"date":"2024-10-04","current":41.264936,"twenty":-14.910808,"median":-6.366387,"eighty":37.949925,"marketCap":7695910491},{"date":"2024-10-11","current":43.570823,"twenty":-14.910808,"median":-6.366387,"eighty":38.317621,"marketCap":8125958449},{"date":"2024-10-18","current":42.73524,"twenty":-14.910808,"median":-6.366387,"eighty":38.444308,"marketCap":7970122255},{"date":"2024-10-25","current":33.906751,"twenty":-14.910808,"median":-6.366387,"eighty":38.759769,"marketCap":7710395266},{"date":"2024-10-31","current":34.976887,"twenty":-14.910808,"median":-6.366387,"eighty":38.759769,"marketCap":7953743991},{"date":"2024-11-08","current":38.315221,"twenty":-14.920651,"median":-6.373244,"eighty":38.775863,"marketCap":8712881178},{"date":"2024-11-15","current":37.699284,"twenty":-14.920651,"median":-6.373244,"eighty":38.959639,"marketCap":8572817127},{"date":"2024-11-22","current":39.610661,"twenty":-14.920651,"median":-6.373244,"eighty":39.15086,"marketCap":9007464289},{"date":"2024-11-29","current":42.532525,"twenty":-14.920651,"median":-6.373244,"eighty":39.285271,"marketCap":9671896246},{"date":"2024-12-06","current":42.712265,"twenty":-14.920651,"median":-6.373244,"eighty":39.549842,"marketCap":9712769029},{"date":"2024-12-13","current":38.834712,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8831013491},{"date":"2024-12-20","current":37.173217,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8453189468},{"date":"2024-12-27","current":38.499344,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8754750859},{"date":"2025-01-03","current":38.468657,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8747772579},{"date":"2025-01-10","current":40.298932,"twenty":-14.930493,"median":-6.380101,"eighty":40.000208,"marketCap":9163977143},{"date":"2025-01-17","current":43.998937,"twenty":-14.930493,"median":-6.380101,"eighty":40.25335,"marketCap":10005358346},{"date":"2025-01-24","current":46.585434,"twenty":-14.930493,"median":-6.380101,"eighty":40.313802,"marketCap":10593527670},{"date":"2025-01-31","current":35.909437,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9652456751},{"date":"2025-02-07","current":35.32268,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9494736407},{"date":"2025-02-14","current":34.0368,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9149091839},{"date":"2025-02-21","current":38.652589,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":10389815982},{"date":"2025-02-28","current":36.887291,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9915303930},{"date":"2025-03-07","current":34.577539,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9294442372},{"date":"2025-03-14","current":32.776935,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":8810440080},{"date":"2025-03-21","current":34.596121,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9299437236},{"date":"2025-03-28","current":34.525509,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9280456754},{"date":"2025-04-04","current":30.9466,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":8318446005},{"date":"2025-04-11","current":31.173301,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":8379383343},{"date":"2025-04-17","current":31.994629,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":8600156318},{"date":"2025-04-25","current":27.828327,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9959758217},{"date":"2025-04-29","current":27.678372,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9906089257}],"updateTime":1746085768545}}}